Sharpen that competitive edge — PTI guides pharma on effective PAT/QbD best practice

Easy-access webinar e-course from PTI helps pharmaceutical manufacturers implement successful Quality by Design strategies.

As the pharmaceutical market becomes ever more competitive, manufacturers need to ensure their processes are as time- and cost-effective as possible. This requires a thorough understanding of the chemical and mechanical properties of the elements used to make a pharmaceutical product, as well as the manufacturing processes involved. In this webinar e-course, Emil Ciurczak will provide a complete overview of implementing QbD, including the economic reasons, regulatory requirements, technologies, concepts for software and compliance, and best practices to successfully roll out QbD with minimal risk. He will also address specific queries in an interactive question and answer session at the end of the webinar. Participants will be able to use the knowledge gained from this course to develop a QbD strategy for their own manufacturing processes, improving quality, reducing variance and time to market, as well as HVAC and materials costs.

PTI’s Managing Director, Rosie Bernard, comments: “In today’s market, pharmaceutical manufacturers really need an edge to stay competitive and maximise their return on investment. At PTI, we understand that the correct implementation of a Quality by Design strategy can make a real difference. In this latest session of our series of webinar e-courses, we provide easy access to Emil’s considerable experience in pharma. Having worked in the industry since the 1970s, he will ensure all who participate in the session leave with a thorough understanding of QbD and the considerations needed to make it successful.”